Source: FierceBiotech When Amgen splashed $400 million upfront on Kyowa Kirin’s anti-OX40 antibody, the world was yet to see midphase…...
Latest News
Crown Laboratories to Acquire StriVectin®, the #1 Independent Prestige Skincare Company in the U.S.
Source: PR Newswire Crown Laboratories, ("Crown"), a leading, fully integrated, global skincare company and a Hildred Capital Management LLC ("Hildred")…...
Cassiopea SpA and Sun Pharma Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in US and Canada
Source: Cassiopea Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel…...
Journey Medical Corporation Enters into a Definitive Agreement with Dr. Reddy’s Laboratories Ltd. to Develop and Commercialize DFD-29 for the Treatment of Rosacea
Source: GlobeNewswire Journey Medical Corporation (“Journey Medical”), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), today announced an…...
Biogen’s aducanumab crosses FDA finish line just in time to save its business
Source: Fierce Pharma The verdict is in: The FDA has approved Biogen’s controversial Alzheimer’s treatment aducanumab. The FDA’s approval on Monday is set…...
Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA®
Source: GlobeNewswire The first and only prescription cloth towelette approved to treat primary axillary hyperhidrosis in people nine-years of age…...
Fortress Biotech’s Partner Company, Journey Medical Corporation, In-licenses and Launches Accutane® for the Treatment of Severe Recalcitrant Nodular Acne
Source: Globe Newswire Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), today announced that Journey Medical Corporation (“Journey Medical”), a partner company…...
MedTech FDA clears novel neck collar to help protect student athletes’ brains from sports-related injuries
Source: FierceBiotech The FDA has cleared a new type of device worn around the back of the neck by…...
UnitedHealth Group’s Optum to buy Change Healthcare for $13B
Source: FierceHealthcare UnitedHealth Group's Optum unit has agreed to buy Change Healthcare for $7.84 billion in cash plus about $5…...
Back to beauty: Former Allergan chief Saunders scoops up aesthetics company in $1.1B deal
Source: FiercePharma In a return to the beauty business, former Allergan CEO Brent Saunders sealed a $1.1 billion deal for…...